SSI Strategy

Monday, June 19th SSI Strategy celebrates the anniversary of the end of slavery in the United States. We pay honor and respect to the people who suffered at the hands of slavery and continue to suffer from the effects of racial inequality.

On this episode of "The Emerging Biotech Leader" our own JEN SEDA, MD joins Kimberly F. Kushner and Ramin Farhood to discuss the future of digital medicine.

They discuss the contrasting combination, or tension as today’s episode describes it, presents two extremes: immense opportunity and innovation and areas of ambiguity for innovators, payors, and the medical community as a whole.

On this episode of The Emerging Biotech Leader, we welcome ou guest Adriana Valenciano, Senior Vice President at SSI Strategy. She is working closely with Usman "Oz" Azam from Empyrean Neuroscience to bring a new class of medicine to the neuro-psych market. Co-hosts Kimberly F. Kushner and Ramin Farhood discuss with Adriana some of the intricacies of getting a new class of medicine to the market, the intersection of neurology and neurosciences, and the importance of the agility and flexibility needed in the early stages of biotech startups.
Listen and subscribe here: https://hubs.ly/Q01sc7jM0

Are you attending ISPOR this week in Vienna? Today, Dr. Benit Maru will be presenting at 12:30 in Hall X2, Level 2, Austria Center, Vienna.
We hope to see you there!

On this episode of the Emerging Biotech Leader, we welcome our guest Usman "Oz" Azam, CEO of the recently launched biotech Empyrean Neuroscience. Hear about what it takes to pioneer an entirely new class of medicine as a biotech startup.

★ Just published a new episode of The Emerging Biotech Leader: The Medical Office is a Value Driver. Listen:

The Emerging Biotech Leader | The Medical Office is a Value Driver Securing funding as an early-stage biotech is no easy feat. There are a few key strategies that help differentiate a funding thesis. What separates burgeoning initiatives from those that fail? Join today’s guest, co-founder, and CEO of SSI Strategy, Doug Locke, whose experience in entrepreneurship...

Today is , the international day for global mental health education, awareness, and advocacy against social stigma. At SSI, we celebrate the contributions made by our pharmaceutical and biotech clients towards progress in addressing diseases related to mental health and look forward to the innovations of the future.

Here are some snapshots from Consulting Magazine's Best Small Firms award ceremony last week.

We want to also give a shout-out to our sister company Acquis Consulting Group for also making the Top 10 Best Small Firms to Work For!

On This Episode of the Emerging Biotech Leader:
Dr. Benit Maru, Sr. VP Medical at SSI, joins our hosts Dr. Ramin Farhood and Kimberly F. Kushner to recap their talk with Dr. Sukumar Nagendran.

They discuss challenges CMO’s face and more. Here are a few takeaways:
• You can’t know everything, so surround yourself with a team that knows to achieve the end goal
• Courage counts. A CMO must take charge, speak their mind, challenge others, and be able to take the hits.
• Understand the dynamics of your leadership team. People on your team don’t always know each other’s backgrounds, strengths, and weaknesses. This is especially true for start-ups.
• Do the right thing for your patients and your company

Listen and Subscribe Here: https://hubs.ly/Q01mC9L70

Consulting Magazine recognized SSI as an honoree for 2022 Best Firms to Work For. SSI Strategy offers clients consulting services to support the needs of the Medical Office including, Medical Affairs, Pharmacovigilance, and Clinical Development by combining business acumen and consulting discipline to service life science industry clients.
https://hubs.ly/Q01hBCPz0